Protagonist Therapeutics Inc
NASDAQ:PTGX
Protagonist Therapeutics Inc
NASDAQ:PTGX
Price:
97.05
USD
0.4%
Market Closed
Market Cap:
$6.2B
Wall Street
Price Targets
PTGX Price Targets Summary
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Wall Street analysts forecast PTGX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PTGX
is 102.55 USD
with a low forecast of 65.65 USD and a high forecast of 123.9 USD.
Lowest
Price Target
65.65
USD
32% Downside
Average
Price Target
102.55
USD
6% Upside
Highest
Price Target
123.9
USD
28% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PTGX's stock price target?
Price Target
102.55
USD
102.55
USD
According to Wall Street analysts, the average 1-year price target for
PTGX
is 102.55 USD
with a low forecast of 65.65 USD and a high forecast of 123.9 USD.
What is Protagonist Therapeutics Inc's Revenue forecast?
Projected CAGR
90%
90%
The
compound annual growth rate
of Protagonist Therapeutics Inc's revenue for the next 3 years is
90%.
